Kwality Pharmaceuticals Limited has announced a closure of its trading window from July 1, 2025, until 48 hours after the announcement of financial results for the quarter ended June 30, 2025. This restriction applies to all designated persons and their immediate relatives to prevent insider trading. The company will notify the date of the board meeting for approving these financial results in due course. This move ensures compliance with internal policies and maintains market integrity for shareholders.